Kyle Kline is Senior Vice President, CFO of GLOBUS MEDICAL INC. Currently has a direct ownership of 0 shares of GMED, which is worth approximately $0. The most recent transaction as insider was on Jan 08, 2026, when has been sold 3,594 shares (Class A Common Stock) at a price of $101.1 per share, resulting in proceeds of $363,353. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Kyle Kline Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 08 2026
SELL
Open market or private sale
$363,353 $101.1 p/Share
3,594 Reduced 100.0%
0 Class A Common Stock
Jan 08 2026
BUY
Exercise of conversion of derivative security
$186,420 $51.87 p/Share
3,594 Added 50.0%
3,594 Class A Common Stock
Dec 01 2025
SELL
Open market or private sale
$1,668,780 $90.0 p/Share
18,542 Reduced 100.0%
0 Class A Common Stock
Dec 01 2025
BUY
Exercise of conversion of derivative security
$1,101,765 $59.42 p/Share
18,542 Added 50.0%
18,542 Class A Common Stock
KK

Kyle Kline

Senior Vice President, CFO
Audubon, PA

Track Institutional and Insider Activities on GMED

Follow GLOBUS MEDICAL INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMED shares.

Notify only if

Insider Trading

Get notified when an Globus Medical Inc insider buys or sells GMED shares.

Notify only if

News

Receive news related to GLOBUS MEDICAL INC

Track Activities on GMED